Medical specialists from France tagged as investigators in clinical trials studying Encephalitis, Tick-Borne

Total 7 results

Assilina Parfut, PharmD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
Trials:
- NCT05607394 (Sub-Investigator)
Conditions:
- Tick-borne Encephalitis
Aurélie Velay-Rusch, MD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
Trials:
- NCT05607394 (Principal Investigator)
Conditions:
- Tick-borne Encephalitis
Baer Baer, MD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
Trials:
- NCT05607394 (Sub-Investigator)
Conditions:
- Tick-borne Encephalitis
Ludovic Glady, MD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
Trials:
- NCT05607394 (Sub-Investigator)
Conditions:
- Tick-borne Encephalitis
Marie-Josée Wendling, MD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
Trials:
- NCT05607394 (Sub-Investigator)
Conditions:
- Tick-borne Encephalitis
Samira Fafi-Kremer, PharmD
Seen in:
- Strasbourg, Service Laboratoire de Virologie - PTM - CHU de Strasbourg - France
Trials:
- NCT05607394 (Sub-Investigator)
Conditions:
- Tick-borne Encephalitis
Sebastien HANTZ, MD
Seen in:
- Limoges, Limoges University Hosiptal
Trials:
- NCT05941546 (Principal Investigator)
Conditions:
- Tick-borne Encephalitis

Clinical Trials on Encephalitis, Tick-Borne

Medical University of Vienna
Austrian Science Fund (FWF)

Completed

Humoral and Cellular Immunity for TBE Vaccination in Allogeneic HSCT Recipients

Tick Borne Encephalitis

Austria
Pfizer

Completed

TBE Seropersistence up to 10 Years After First Booster in Adults

Tick-borne Encephalitis (TBE)

Poland
National Institute of Allergy and Infectious Diseases...
National Institutes of Health (NIH)

Terminated

Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) (TBEV)

Tick-Borne Disease | Encephalitis, Tick-Borne | Tick-Borne Encephalitis | Glycoprotein E, Flavivirus | NSI Protein, Flavivirus

United States
Sykehuset Telemark
Norwegian Institute of Public Health; Oslo University Hospital; Sorlandet Hospital... and other collaborators

Recruiting

The Norwegian Tick Born Encephalitis Study (NOTES)

Tick-Borne Encephalitis, European

Norway
Pfizer

Completed

Study to Evaluate the Immunogenicity, Safety, and Tolerability of a Tick-Borne Encephalitis (TBE) Vaccine in Healthy Japanese Participants 1 Year of Age and Older

Tick-Borne Encephalitis

Japan
GlaxoSmithKline
Novartis Vaccines

Completed

Study to Evaluate Long Term Immunogenicity up to 10 Years After the First Booster Immunization With Tick Borne Encephalitis Vaccine in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

Virus Diseases | Tick Borne Encephalitis

Czechia
Novartis Vaccines

Completed

An Extension Study to Determine the Persistence of Tick-borne Encephalitis (TBE)-Specific Antibody Responses Among Children and Adolescents Previously Immunized Against TBE

Tick Borne Encephalitis (TBE)

Germany
National Institute of Allergy and Infectious Diseases...
Johns Hopkins Bloomberg School of Public Health

Completed

Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults

Tick-Borne Encephalitis

United States
University Medical Centre Ljubljana
University of Ljubljana School of Medicine, Slovenia

Recruiting

Tick-borne Encephalitis and Borrelial Antibodies in Serum

Tick Borne Encephalitis

Slovenia
University of Surrey

Completed

Cervicovaginal Immune Responses to 3 Deltoid or Thigh Intramuscular (IM) TicoVac (CRC306)

Tick-Borne Encephalitis

United Kingdom

Medical specialists from France tagged as investigators in clinical trials studying Encephalitis, Tick-Borne

Clinical Trials on Encephalitis, Tick-Borne

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations